Adbry® (tralokinumab-ldrm) Autoinjector Now Available for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis (AD) in the U.S.
LEO Pharma Inc. announced today the availability of the Adbry® (tralokinumab-ldrm) 300 mg/2 mL single-dose autoinjector in ...
Monthly Prescribing Reference3d
Adbry Autoinjector Now Available for Adults With Atopic Dermatitis
A new single-dose autoinjector presentation of Adbry ® (tralokinumab-ldrm) is now available for use in the treatment of moderate to severe atopic dermatitis not adequately controlled with topical ...
Morningstar6d
Adbry® (tralokinumab-ldrm) Autoinjector Now Available for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis (AD) in the U.S.
LEO Pharma Inc. announced today the availability of the Adbry® (tralokinumab-ldrm) 300 mg/2 mL single-dose autoinjector in the United States. Adbry is currently indicated in the U.S. for patients ...
BioWorld6d
Lilly’s Ebglyss enters US atopic dermatitis market with FDA nod
Eli Lilly and Co.’s Ebglyss (lebrikizumab) becomes the latest U.S. entrant in the increasingly competitive atopic dermatitis space, following FDA approval of the IL-13-targeting antibody, which will ...
dermatologyadvisor5d
Adbry Autoinjector Now Available for Adults With Atopic Dermatitis
The Adbry autoinjector is for use in adults only. The Adbry autoinjector is available in a 300 mg/2 mL dosage strength and is intended for use in adults only. The device includes a push-down mechanism ...
pharmaphorum6d
LEO Pharma's Adtralza approved by MHRA, EC for adolescent atopic dermatitis
It is also approved for adults in the US under the tradename Adbry. Vice president and general manager of UK & Ireland at LEO Pharma, Sarah Kleinpeter, said: “We are pleased that adolescents ...
PipelineReview.com5d
Adbry® (tralokinumab-ldrm) Autoinjector Now Available for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis (AD) in the U.S.
MADISON, NJ, USA I September 17, 2024 I LEO Pharma Inc. announced today the availability of the Adbry ® (tralokinumab-ldrm) 300 mg/2 mL single-dose autoinjector in the United States. Adbry is ...